Dr. Chandler H. Park

Dr. Chandler H. Park, MD, MSc, is a medical oncologist specializing in precision oncology and solid tumors, with a focus on genitourinary cancers. He practices at the Norton Cancer Institute in Kentucky and serves as clinical faculty at the University of Louisville School of Medicine, where he contributes to the Molecular Tumor Board and oncology education. Dr. Park earned his medical degree from the University of Louisville and completed his residency and fellowship training in internal medicine, hematology, and oncology. He also holds a Master of Science in Biophysics and a Bachelor of Science in Biomedical Engineering. He is board-certified in Medical Oncology, Hematology, and Internal Medicine.

Dr. Park’s clinical work centers on integrating molecular diagnostics and immunotherapies into cancer treatment, with an emphasis on therapy sequencing and emerging targeted agents. He has contributed to educational efforts around the use of antibody-drug conjugates and immune checkpoint inhibitors in bladder and prostate cancers. His expertise in applying genomics to community oncology has positioned him as a thought leader in bridging academic research and real-world practice, with a strong emphasis on accessibility and patient engagement.

In addition to his clinical and academic roles, Dr. Park is a nationally recognized medical educator and communicator. He has authored hundreds of educational articles for physicians and patients and is a frequent contributor to platforms such as Medscape and Newsweek. He currently serves as President of the Kentucky Society of Clinical Oncology and is actively involved in professional society leadership and mentorship. Through his dedication to innovation, education, and precision medicine, Dr. Chandler Park continues to advance the field of community-based cancer care.